SignatureFD’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$17.4K Buy
940
+15
+2% +$277 ﹤0.01% 2484
2026
Q2
$16.4K Sell
925
-411
-31% -$6.48K ﹤0.01% 2433
2026
Q1
$19.2K Buy
1,336
+32
+2% +$531 ﹤0.01% 2219
2025
Q4
$23K Buy
1,304
+411
+46% +$6.8K ﹤0.01% 2054
2025
Q3
$14K Hold
893
– – ﹤0.01% 2267
2025
Q2
$9.9K Hold
893
– – ﹤0.01% 2353
2025
Q1
$10.4K Sell
893
-71
-7% -$914 ﹤0.01% 2335
2024
Q4
$13.2K Sell
964
-161
-14% -$2.33K ﹤0.01% 2260
2024
Q3
$18.8K Buy
1,125
+161
+17% +$2.35K ﹤0.01% 2071
2024
Q2
$11.4K Sell
964
-2
-0.2% -$23 ﹤0.01% 2210
2024
Q1
$11.6K Buy
966
+105
+12% +$1.56K ﹤0.01% 2248
2023
Q4
$14.5K Sell
861
-881
-51% -$12.5K ﹤0.01% 2081
2023
Q3
$26.1K Sell
1,742
-62
-3% -$1.05K ﹤0.01% 1720
2023
Q2
$34K Buy
1,804
+605
+50% +$9.6K ﹤0.01% 1633
2023
Q1
$21.5K Buy
1,199
+333
+38% +$5.56K ﹤0.01% 1832
2022
Q4
$7.21K Buy
+866
New +$6.46K ﹤0.01% 2288
2022
Q3
– Sell
-100
Closed -$2K – 3330
2022
Q2
$2K Buy
+100
New +$2.1K ﹤0.01% 2799

Other funds holding SHC

SignatureFD's SHC Position: Q3 2026 in Review

SignatureFD increased its Sotera Health (SHC) stake by 1.6% in Q3 2026, buying an estimated $277 and bringing the position to 940 shares worth $17.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2484.

SignatureFD first reported a position in SHC in Q2 2022 and has held it in 17 quarters since. The position peaked at $34K in Q2 2023. 348 funds tracked by Wall St. Rank hold SHC as of Q3 2026.

  • SignatureFD held 940 shares of Sotera Health worth $17.4K as of Q3 2026.
  • SignatureFD bought 15 Sotera Health shares in Q3 2026, an estimated $277.
  • Sotera Health made up ﹤0.01% of SignatureFD's portfolio in Q3 2026, its #2484 holding.
  • SignatureFD first reported a position in Sotera Health in Q2 2022 and has held it in 17 quarters since.
  • SignatureFD's Sotera Health position peaked at $34K in Q2 2023.
  • 348 funds tracked by Wall St. Rank held Sotera Health as of Q3 2026.

Based on SignatureFD's 13F filing for Q3 2026, filed 23 Oct 2026.